Nuvalent Inc vs Koninklijke Philips NV — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Koninklijke Philips NV is far larger — about 2.7× Nuvalent Inc's market cap, and Koninklijke Philips NV pays a 3.79% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | PHG | |
|---|---|---|
Market Cap | $9.81B | $26.19B |
Sector | Technology | Health |
52-Week High | $123.96 | $32.91 |
52-Week Low | $72.16 | $24.54 |
Enterprise Value | $8.52B | $32.46B |
Dividend Yield | — | 3.79% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →